Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$5.4B |
| 2 |
NVIDIA
NVDA
|
+$388M |
| 3 |
Microsoft
MSFT
|
+$182M |
| 4 |
Amazon
AMZN
|
+$177M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$163M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$213M |
| 2 |
Broadcom
AVGO
|
+$103M |
| 3 |
Union Pacific
UNP
|
+$100M |
| 4 |
ETHA
iShares Ethereum Trust ETF
ETHA
|
+$89.9M |
| 5 |
Marvell Technology
MRVL
|
+$89.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.68% |
| 2 | Industrials | 8.46% |
| 3 | Financials | 6.55% |
| 4 | Consumer Discretionary | 5.99% |
| 5 | Healthcare | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Valero Energy
VLO
$98B
| $633K | ﹤0.01% |
3,887
-12,157
| -76% | -$2.06M |
|
1302
Eversource Energy
ES
$26.8B
| $632K | ﹤0.01% |
9,385
+2,399
| +34% | +$168K |
|
1303
SM Energy
SM
$8.49B
| $631K | ﹤0.01% |
33,749
-2,741
| -8% | -$55.5K |
|
1304
CALL
Abercrombie & Fitch
ANF
$4.84B
| $629K | ﹤0.01% |
+5,000
| New | +$437K |
|
|
1305
PUT
Abercrombie & Fitch
ANF
$4.84B
| $629K | ﹤0.01% |
+5,000
| New | +$437K |
|
1306
Rogers Communications
RCI
$19.8B
| $627K | ﹤0.01% |
+16,628
| New | +$623K |
|
1307
Janux Therapeutics
JANX
$1.14B
| $627K | ﹤0.01% |
+45,453
| New | +$1.07M |
|
1308
Aptiv
APTV
$9.68B
| $627K | ﹤0.01% |
8,235
+4,716
| +134% | +$379K |
|
|
THS
1309
DELISTED
Treehouse Foods
THS
| $626K | ﹤0.01% |
+26,543
| New | +$579K |
|
1310
Weatherford International
WFRD
$6.32B
| $624K | ﹤0.01% |
+7,973
| New | +$579K |
|
1311
Dana Inc
DAN
$3.24B
| $623K | ﹤0.01% |
26,221
-106,829
| -80% | -$2.26M |
|
1312
Aurinia Pharmaceuticals
AUPH
$2.23B
| $618K | ﹤0.01% |
38,764
-48,064
| -55% | -$681K |
|
|
CCII
1313
Cohen Circle Acquisition Corp II
CCII
$358M
| $614K | ﹤0.01% |
60,000
-20,000
| -25% | -$205K |
|
1314
Harley-Davidson
HOG
$2.86B
| $612K | ﹤0.01% |
29,866
-189,737
| -86% | -$4.66M |
|
1315
Structure Therapeutics
GPCR
$3.56B
| $607K | ﹤0.01% |
+8,727
| New | +$356K |
|
1316
Franklin Electric
FELE
$4.5B
| $606K | ﹤0.01% |
6,340
-18,725
| -75% | -$1.79M |
|
|
GOOS
1317
Canada Goose Holdings
GOOS
$803M
| $604K | ﹤0.01% |
+46,621
| New | +$620K |
|
1318
Pacira BioSciences
PCRX
$1.02B
| $603K | ﹤0.01% |
+23,304
| New | +$554K |
|
1319
CALL
Urban Outfitters
URBN
$6.49B
| $602K | ﹤0.01% |
+8,000
| New | +$566K |
|
|
1320
PUT
Urban Outfitters
URBN
$6.49B
| $602K | ﹤0.01% |
+8,000
| New | +$566K |
|
1321
Simulations Plus
SLP
$372M
| $602K | ﹤0.01% |
33,009
+21,529
| +188% | +$378K |
|
1322
Wingstop
WING
$3.1B
| $602K | ﹤0.01% |
2,523
-6,675
| -73% | -$1.65M |
|
1323
Steris
STE
$23.1B
| $601K | ﹤0.01% |
+2,370
| New | +$595K |
|
1324
Cal-Maine
CALM
$3.93B
| $600K | ﹤0.01% |
7,538
-17,881
| -70% | -$1.57M |
|
1325
BBB Foods
TBBB
$6.14B
| $600K | ﹤0.01% |
17,963
-4,055
| -18% | -$121K |
|
Similar funds
Steve Schonfeld's Q4 2025 Portfolio in Review
As of Q4 2025, Steve Schonfeld held 2,774 positions worth $22.6B, up 28% from $17.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Steve Schonfeld deployed $4.53B of net new capital in Q4 2025, opening 620 new positions and adding to 589 existing holdings. Its largest new stake was Medline Inc: 1,945,050 shares worth $81.7M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $213M trimmed.
- Steve Schonfeld's largest Q4 2025 buy was Medline Inc: 1,945,050 shares worth $81.7M.
- Steve Schonfeld added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $5.4B increase.
- Steve Schonfeld's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $213M.
- Steve Schonfeld fully exited Southwest Airlines in Q4 2025, selling an estimated $73.9M.
- Steve Schonfeld's ten largest holdings make up 41% of its $22.6B portfolio in Q4 2025.
- Steve Schonfeld opened 620 new positions and closed 789 in Q4 2025.
- Steve Schonfeld's portfolio value rose 28% quarter-over-quarter to $22.6B.
Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.